What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: A modified Delphi process

dc.contributor.authorFarrell, Barbara
dc.contributor.authorTsang, Corey
dc.contributor.authorRaman-Wilms, Lalitha
dc.contributor.authorIrving, Hannah
dc.contributor.authorConklin, James
dc.contributor.authorPottie, Kevin
dc.date.accessioned2026-06-02T19:17:24Z
dc.date.available2026-06-02T19:17:24Z
dc.date.issued2015-04-07
dc.description© 2015 Farrell et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
dc.description.abstractPolypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it difficult to carry out. Deprescribing guidelines would facilitate this process. The aim of this paper is to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review to identify potentially inappropriate medications for the elderly, an expert panel to develop survey content and three survey rounds to seek consensus on priorities. Panel participants included three pharmacists, two family physicians and one social scientist. Sixty-five Canadian geriatrics experts (36 pharmacists, 19 physicians and 10 nurse practitioners) participated in the survey. Twenty-nine drugs/drug classes were included in the first survey with 14 reaching the required (≥ 70%) level of consensus, and 2 new drug classes added from qualitative comments. Fifty-three participants completed round two, and 47 participants completed round three. The final five priorities were benzodiazepines, atypical antipsychotics, statins, tricyclic antidepressants, and proton pump inhibitors; nine other drug classes were also identified as being in need of evidence-based deprescribing guidelines. The Delphi consensus process identified five priority drug classes for which expert clinicians felt guidance is needed for deprescribing. The classes of drugs that emerged strongly from the rankings dealt with mental health, cardiovascular, gastroenterological, and neurological conditions. The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based deprescribing guidelines are a priority in the care of the elderly.
dc.description.sponsorshipOntario Ministry of Health and Long-Term Care.
dc.identifier.urihttps://doi.org/10.1371/journal.pone.0122246
dc.identifier.urihttps://hdl.handle.net/10012/23517
dc.language.isoen
dc.publisherPublic Library of Science
dc.relation.ispartofseriesPLoS ONE; 10(4); e0122246
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectantipsychotics
dc.subjectgeriatric care
dc.subjectgeriatrics
dc.subjectantiplatelet therapy
dc.subjectreuptake inhibitors
dc.subjectantidepressants
dc.subjectphysicians
dc.subjectstatins
dc.titleWhat are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: A modified Delphi process
dc.typeArticle
dcterms.bibliographicCitationFarrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K (2015) What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process. PLoS ONE 10(4): e0122246. https://doi.org/10.1371/journal.pone.0122246
uws.contributor.affiliation1Faculty of Health
uws.contributor.affiliation2School of Pharmacy
uws.peerReviewStatusReviewed
uws.scholarLevelFaculty
uws.typeOfResourceTexten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file - 2026-06-02T151317.479.pdf
Size:
289.12 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
4.47 KB
Format:
Item-specific license agreed upon to submission
Description: